The US Supreme Court on Monday temporarily extended access to abortion pill Mifepristone via telehealth and mail.
Last Monday the Supreme Court temporarilyrestoredaccess to abortion pill Mifepristone via telehealth and mail.
Last week, Justice Samuel Alito granted temporary relief after Mifepristone’s maker, Danco Laboratories and the generic version’s manufacturer, GenBioPro, filed a petition.
On Monday, Justice Alito extended access to Mifepristone until at least Thursday.
“The Supreme Court is leaving women’s access to a widely used abortion pill untouched until at least Thursday, while the justices consider whether to allow restrictions on the drug, mifepristone, to take effect,” the Associated Pressreported.
“Justice Samuel Alito’s order Monday allows women seeking abortions to continue obtaining the pill at pharmacies or through the mail, without an in-person visit to a doctor. It prevents restrictions on mifepristone imposed by a federal appeals court from taking effect for the time being,” the AP said.
A federal appeals court on Fridayblockednationwide access to abortion pill prescriptions via telehealth and mail.
A three-judge panel on the Fifth Circuit Court of Appeals unanimously ruled that abortion pills such as Mifepristone must be distributed in person.
Louisiana filed the lawsuit after the FDA allowed Mifepristone to be distributed via telehealth and mail during the Covid pandemic.
In 2023, the ‘Covid’ change to how abortion pills were distributed became permanent.
Source: The Gateway Pundit
